Our pioneering hybrid scheme revolutionizes the tourism industry by merging innovative strategies with a primary focus on growth and sustainability. As the first of its kind, this scheme addresses the evolving needs of the tourism sector, integrating traditional and modern practices to drive innovation, efficiency, and resilience. At its core, the scheme emphasizes boosting collaboration and synergy through strategic partnerships and alliances, creating a robust network that enhances competitiveness.
Yong Tai Berhad, in collaboration with Shenzhen Kangtai of China, spearheaded the Phase 3 clinical trial for the Covid-19 vaccine in Malaysia. With a commitment to advancing public health and safety, Yong Tai Berhad played a pivotal role in facilitating this crucial trial, contributing to global efforts in combating the pandemic. Through this partnership, Yong Tai reaffirms its dedication to promoting health and well-being within the Malaysian community and beyond.
Founded in Malaysia in 1971, Yong Tai Berhad has successfully diversified its portfolio from garment manufacturing to tourism property development.
Copyright © Copyright © Yong Tai Berhad [199401025505 (311186-T)].Website managed by Exabytes. All rights reserved.